Skip to main content

Prototype Prescribing Outlier Dashboard for Arun Integrated Care (Aic) PCN

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all PCNs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given PCN is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all PCN's chemical:subparagraph ratios is provided, with this PCN's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Arun Integrated Care (Aic) PCN is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Other vaginal/vulva changes preparations 1 Preparations for vaginal/vulval changes 1,161 0.00 0.00 0.00 16.50
Methyl salicylate/levomenthol 12 Rubefacients, topical NSAIDS, capsaicin and poultice 2,301 0.01 0.00 0.00 14.36
Cetylpyridinium chloride 6 Mouth-washes, gargles and dentifrices 51 0.12 0.00 0.01 12.32
Camellia sinensis extract 1 Preparations for warts and calluses 20 0.05 0.00 0.00 12.19
Diphenhydramine hydrochloride 2 Topical local anaesthetics and antipruritics 99 0.02 0.00 0.00 11.70
Celiprolol hydrochloride 106 Beta-adrenoceptor blocking drugs 16,797 0.01 0.00 0.00 7.24
Benzocaine 10 Drugs for oral ulceration and inflammation 163 0.06 0.00 0.01 6.94
Pridinol mesilate 13 Skeletal muscle relaxants 572 0.02 0.00 0.00 5.20
Inclisiran 1 Lipid-regulating drugs 34,228 0.00 0.00 0.00 4.11
Celecoxib 535 Non-steroidal anti-inflammatory drugs 4,468 0.12 0.03 0.02 3.68

Prescribing where Arun Integrated Care (Aic) PCN is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Naftidrofuryl oxalate 0 Peripheral vasodilators and related drugs 42 0.00 0.67 0.28 -2.44
    Chlorhexidine gluconate 45 Mouth-washes, gargles and dentifrices 51 0.88 0.98 0.05 -2.07
    Sodium picosulfate 0 Bowel cleansing preparations 1 0.00 0.70 0.35 -2.04
      Dexamethasone 548 Otitis externa 854 0.64 0.78 0.07 -1.88
      Lamotrigine 788 Control of epilepsy 11,549 0.07 0.11 0.03 -1.78
      Moxonidine 36 Centrally-acting antihypertensive drugs 103 0.35 0.69 0.19 -1.73
      Risperidone 356 Antipsychotic drugs 4,060 0.09 0.15 0.04 -1.53
      Sevelamer 0 Phosphate binding agents 3 0.00 0.43 0.28 -1.52
        Octreotide acetate 0 Somatostatin analogues 4 0.00 0.62 0.43 -1.45
          Clobetasone butyrate 337 Topical corticosteroids 3,867 0.09 0.13 0.03 -1.44